3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Stroke
1
Recurrence
1
Ovarian Neoplasms
1
Neurologic Manifestations
1
Melanoma
1
Margins of Excision
1
Malignant Solid Neoplasm
1
Malignant Female Reproductive System Neoplasm
1
Inflammatory Breast Neoplasms
1
Glioblastoma
1
Fallopian Tube Neoplasms
1
Communication
1
Colorectal Neoplasms
1
Caregiver Burden
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Brain Neoplasms
1
Brain Injuries, Traumatic
1
Brain Injuries
1
Advanced Malignant Solid Neoplasm
1
Interventions
Rituximab
18
Cyclophosphamide
17
Prednisone
12
Doxorubicin
12
Vincristine
9
Lenalidomide
7
ibrutinib
6
obinutuzumab
5
glofitamab
5
Magnetic Resonance Spectroscopy
5
polatuzumab vedotin
4
fludarabine
4
Prednisolone
4
Oxaliplatin
4
Gemcitabine
4
Etoposide
4
venetoclax
3
pembrolizumab
3
fludarabine phosphate
3
Whole-Body Irradiation
3
Specimen Handling
3
R-CHOP protocol
3
Cyclosporine
3
Biopsy
3
zanubrutinib
2
prednylidene
2
deltacortene
2
acalabrutinib
2
Mycophenolic Acid
2
Ifosfamide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
Palliative Care
×
30 days
×
Clear all
No trials found.